These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32574951)

  • 1. Neurofilament light in blood - What more is needed for clinical implementation in multiple sclerosis?
    Zetterberg H
    EBioMedicine; 2020 Jul; 57():102826. PubMed ID: 32574951
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurofilaments in progressive multiple sclerosis: a systematic review.
    Williams T; Zetterberg H; Chataway J
    J Neurol; 2021 Sep; 268(9):3212-3222. PubMed ID: 32447549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofilament light as a prognostic marker in multiple sclerosis.
    Salzer J; Svenningsson A; Sundström P
    Mult Scler; 2010 Mar; 16(3):287-92. PubMed ID: 20086018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in consecutive serum neurofilament light levels in healthy controls and multiple sclerosis patients.
    Bridel C; Verberk IMW; Heijst JJA; Killestein J; Teunissen CE
    Mult Scler Relat Disord; 2021 Jan; 47():102666. PubMed ID: 33291033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
    Håkansson I; Tisell A; Cassel P; Blennow K; Zetterberg H; Lundberg P; Dahle C; Vrethem M; Ernerudh J
    Eur J Neurol; 2017 May; 24(5):703-712. PubMed ID: 28261960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
    Siller N; Kuhle J; Muthuraman M; Barro C; Uphaus T; Groppa S; Kappos L; Zipp F; Bittner S
    Mult Scler; 2019 Apr; 25(5):678-686. PubMed ID: 29542376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Neurofilament Light Chain for Multiple Sclerosis Relapses: Too Little Too Late?
    Silbermann E; Spain RI
    Neurology; 2024 May; 102(9):e209456. PubMed ID: 38648605
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light Chain.
    Abdelhak A; Kuhle J; Green AJ
    JAMA Neurol; 2023 Jun; 80(6):542-543. PubMed ID: 37010852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma neurofilament light in progressive multiple sclerosis.
    Zetterberg H
    Acta Neurol Scand; 2020 Jan; 141(1):14-15. PubMed ID: 31618445
    [No Abstract]   [Full Text] [Related]  

  • 10. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
    Sejbaek T; Nielsen HH; Penner N; Plavina T; Mendoza JP; Martin NA; Elkjaer ML; Ravnborg MH; Illes Z
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1324-1330. PubMed ID: 31611264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis.
    Kuhle J; Leppert D; Petzold A; Regeniter A; Schindler C; Mehling M; Anthony DC; Kappos L; Lindberg RL
    Neurology; 2011 Apr; 76(14):1206-13. PubMed ID: 21346223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF neurofilament light: A universal risk biomarker in multiple sclerosis?
    Khalil M; Salzer J
    Neurology; 2016 Sep; 87(11):1068-9. PubMed ID: 27521432
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis.
    Berger T; Stüve O
    Neurology; 2019 Mar; 92(10):451-452. PubMed ID: 30737335
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum neurofilament light and prediction of multiple sclerosis in clinically isolated syndrome.
    Zetterberg H; Svenningsson A
    Neurology; 2019 Feb; 92(7):313-314. PubMed ID: 30635493
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurofilament in clinical practice: Is the multiple sclerosis community ready?
    Moccia M; Terracciano D; Brescia Morra V; Castaldo G
    Mult Scler; 2024 May; 30(6):643-645. PubMed ID: 38605490
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
    Barro C; Benkert P; Disanto G; Tsagkas C; Amann M; Naegelin Y; Leppert D; Gobbi C; Granziera C; Yaldizli Ö; Michalak Z; Wuerfel J; Kappos L; Parmar K; Kuhle J
    Brain; 2018 Aug; 141(8):2382-2391. PubMed ID: 29860296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editors' Note: Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled Trials.
    Ganesh A; Galetta S
    Neurology; 2022 Oct; 99(14):630. PubMed ID: 36192187
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
    Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Author Response: Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled Trials.
    Leppert D; Kropshofer H; Häring D; Dahlke F; Patil A; Meinert R; Tomic D; Kappos L; Kuhle J
    Neurology; 2022 Oct; 99(14):631. PubMed ID: 36192181
    [No Abstract]   [Full Text] [Related]  

  • 20. Reader Response: Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled Trials.
    Barro C
    Neurology; 2022 Oct; 99(14):630-631. PubMed ID: 36192183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.